An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia
- PMID: 30640980
- DOI: 10.1111/jth.14383
An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia
Abstract
Essentials A pilot study for External Quality Assessment for testing of HIT is described. The qualitative accordance for the PF4/heparin IgG test was 97.6%. The qualitative accordance for functional HIT tests was considerably lower. External Quality Assessment for functional HIT tests is required. SUMMARY: Objective Heparin-induced thrombocytopenia (HIT) is a potentially life-threatening complication of heparin exposure. Diagnosis is most reliable using a combination of an enzyme immunoassay (EIA) that detects antibodies against platelet factor 4 (PF4)/heparin complexes ("antigen" assay) and a "functional" assay that detects platelet-activating properties of the pathogenic HIT antibodies. No External Quality Assessment (EQA) is available for a combination of the tests. Here we report on the results of the first international EQA. Methods The pilot EQA was organized by the Department of Transfusion Medicine, Universitätsmedizin Greifswald, Germany. Six serum samples of patients, which were referred to Greifswald for HIT diagnosis, and one negative control sample were distributed to seven participants in Germany, Canada, and Singapore. Participants were asked to report the optical density (OD) values of their local EIA test for IgG-specific antibodies against the PF4/heparin complexes and the results for a functional assay (HIPA or SRA). Consensus was defined as a minimum 70% agreement, i.e., agreement among at least five of the seven participating laboratories. Results and conclusion Six out of seven participants reported results for EIA, with a high quantitative accordance (97.6%). For the functional assay, consensus was reached for all samples except the negative control, for which some participants reported nonspecific reactivity. All HIT-negative samples were correctly diagnosed by all participants; for HIT-positive samples, consensus of 70% was reached. Although the limited availability of sample material is an obstacle to overcome, an EQA combining both EIA and functional testing is feasible.
Keywords: blood platelets; heparin; laboratory proficiency testing; platelet factor 4; thrombocytopenia.
© 2019 International Society on Thrombosis and Haemostasis.
Similar articles
-
Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.Thromb Haemost. 2010 Aug;104(2):402-9. doi: 10.1160/TH10-01-0002. Epub 2010 Jun 10. Thromb Haemost. 2010. PMID: 20539902
-
Heparin-induced thrombocytopenia: An international assessment of the quality of laboratory testing.J Thromb Haemost. 2019 Dec;17(12):2123-2130. doi: 10.1111/jth.14611. Epub 2019 Sep 25. J Thromb Haemost. 2019. PMID: 31420903
-
Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.J Thromb Haemost. 2018 Dec;16(12):2520-2525. doi: 10.1111/jth.14306. Epub 2018 Nov 20. J Thromb Haemost. 2018. PMID: 30269432 Free PMC article.
-
[Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].Rinsho Byori. 2005 Jul;53(7):622-9. Rinsho Byori. 2005. PMID: 16104531 Review. Japanese.
-
Testing for heparin-induced thrombocytopenia antibodies.Transfus Med Rev. 2006 Oct;20(4):259-72. doi: 10.1016/j.tmrv.2006.05.001. Transfus Med Rev. 2006. PMID: 17008164 Review.
Cited by
-
Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort study.Thromb Res. 2023 Sep;229:198-208. doi: 10.1016/j.thromres.2023.07.011. Epub 2023 Jul 20. Thromb Res. 2023. PMID: 37541168
-
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia.Blood. 2022 Jul 21;140(3):274-284. doi: 10.1182/blood.2021014240. Blood. 2022. PMID: 35377938 Free PMC article.
-
Heparin-induced Thrombocytopenia Diagnosis: A Retrospective Study Comparing Heparin-induced Platelet Activation Test to 14 C-serotonin Release Assay.TH Open. 2021 Sep 24;5(4):e507-e512. doi: 10.1055/a-1653-5065. eCollection 2021 Oct. TH Open. 2021. PMID: 34778697 Free PMC article.
-
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.Blood. 2021 Oct 7;138(14):1269-1277. doi: 10.1182/blood.2021012938. Blood. 2021. PMID: 34280256 Free PMC article.
-
A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination.Blood. 2021 Jul 1;137(26):3656-3659. doi: 10.1182/blood.2021012064. Blood. 2021. PMID: 33945605 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous